Pre-ASCO Movers: CLVS, INCY, PBYI
Volatility Up as ASCO Approaches The ASCO Annual Meeting is not till the end of the month but news regarding abstract titles and clinical data that will be presented at ASCO moved stocks today. Many immuno-oncology stocks have been hard hit in the 2014 sell-off as investors have moved out of...
Biotechnology ETFs And Funds: How Do They Compare After Sell-Off? Update- 1
Update May 30-Fidelity Select Biotech (FBIOX) Fund is lagging Top ETFs FBT and IBB Compared to 2013 when FIDO beat the ETFs it is lagging post February bubble and YTD. It would be difficult to analyze why this happened but my guess is that: FIDO went chasing "bubble" stocks like AEGR, ICPT...
Biotech Bubble has Burst-Back to Basics: ABBV, HOLX
Risk-Off -Stay With Large Caps In case you missed it the speculative frenzy in biotech stocks is over for now but there are always trading opportunities for the short and long term. We recently posted our Q1 Rayno Life Science update for biopharmaceuticals and the large cap stocks are holding...
Rayno Biopharmaceutical Stocks: April 2014 Update After Sell-Off… Update 10/6/14
Note: Prices are updated as of 10/6/14 Stocks on the list that are lower from 5/2 are: ALKS, ARIA,CBST, IMGN (dropped)-all others are up. Biotech Stocks Are Down 5-10% in April-IBB is up only 1% YTD but 32% over one year May 2 Mid-day trading: NASDAQ 41358 up 0.25%, FBT 74.10IBB $229.4, XBI...
Large Cap Biopharmaceuticals 2014 Q2 Metrics: ALXN, AMGN, BIIB.. Update
Update August 5, 2014 Large Cap Biopharmaceutical Stocks Includes Q1 Earnings Reports (except REGN due 5/8) Rayno Focus Picks: ALXN, AMGN, BIIB, FBT, GILD, REGN, RHHBY Large cap stocks are core holdings especially now that sector momentum is easing. ABBV dropped due to inversion play and...